and irritability of their daughters; still others are worried by their daughters' anhedonia, perfectionism and rigidity. Depending on education level and the interrelated medical knowledge they are also concerned with potential longer term somatic problems that may result from anorexia nervosa; examples include infertility and osteoporosis.
This conglomeration of frequent and infrequent complaints is brought forward upon the initial contact with medical services. In contrast to some decades ago, nowadays many more physicians are knowledgeable about the eating disorder and as a consequence are likely to more or less rapidly refer to a specialist. This may be a reason underlying the observation of a secular trend towards a higher BMI at referral [2] . Obviously, diagnosis can be tricky if patients and parents bring forward less frequent complaints and do not mention weight loss; in addition, the underweight may not be readily discernible either because it is not severe enough to readily merit attention or it is in some way concealed by the patient.
Either the initially contacted physician or the specialist may refer the patient for inpatient treatment if the health of the patient is acutely compromised by for instance a low body mass index (BMI; e.g. <14 kg/m 2 ), reduced fluid intake, continuous weight loss, complete lack of food intake, failure to gain weight on an outpatient basis, serious comorbid psychiatric or somatic disorders including severe depression, suicidality, bradycardia and hypothermia. In many cases, however, inpatient treatment is not initiated immediately after the physician has deemed it necessary. The patients and their parents need to find a suitable treatment center, which provides a specialized outpatient-and if necessary inpatient-treatment program; this facility must be in a position to admit the patient. Frequently, the patient's reluctance to start inpatient treatment in combination with parental incertitude also entails a further delay.
The core symptomatology of anorexia nervosa consists of an intertwining of primary behavioral features and cognitions with mental and physical symptoms related to starvation, which differ depending on age and stage of the disorder [5, 9] . As such, anorexia nervosa represents a true psychosomatic disorder in the sense that both soma and psyche are affected. Patients restrict their energy intake and/or increase their energy expenditure and as a consequence lose weight. At a more or less early stage of their disorder, they establish an initial contact with medical services, in most cases a pediatrician or general practitioner. In childhood and adolescence, parents or caregivers are frequently the driving force behind this initial presentation; the young patients themselves are often reluctant to seek medical help. In single cases, teachers, friends and relatives of the patient may be crucial for the initiation of help seeking behavior by persuading the patient and her caregivers to contact a physician. However, when queried accordingly, some patients do admit that their mood and their concentration have deteriorated and that they no longer have the drive to pursue social contacts. They often also to some extent agree that somatic symptoms such as loss of hair, pallor, sleep disturbances, increased cold sensitivity, and a reduced fitness are worrisome; in contrast, one of the four cardinal DSM-IV symptoms, namely amenorrhea, is frequently not mentioned as a complaint. The parents are mostly worried by the aberrant eating behavior, recent weight loss and the ensuing underweight; they may also seek help because of hyperactivity or depressed mood
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Can we identify factors that predict at what BMI patients are admitted for inpatient treatment? Upon acknowledgement of the complexity of the aforementioned issues and decision processes this would seem rather improbable. Surprisingly, however, a single factor, namely premorbid BMI, explains approximately 20-35 % of the variance of the BMI at admission. Coners et al. [3] initially found a rather strong correlation in the magnitude of r = 0.6 between premorbid BMI age percentile and referral BMI among 42 adolescent patients with anorexia nervosa. This correlation may actually even have been underestimated somewhat, because the premorbid BMI was merely estimated based on self-recalled premorbid weight and height measured upon referral. Take for instance a patient whose disease duration lasted 1.5 years prior to referral. Whereas the patient's obsession with weight may indeed frequently allow her to correctly recall her weight directly prior to the initial weight loss, this does not hold true for body height.
To analyze to what extent results are dependent on the use of measured current height-a procedure which systematically under estimates BMI at onset of the eating disorder due to a potentially too high denominator in kg/m 2 in still growing young females-Coners et al. also estimated individual height prior to the onset of the eating disorder by subtracting the mean increment in height between age at onset of anorexia nervosa from measured height at referral to then recalculate premorbid BMI. Overall, the results were very similar; again approximately 35 % of the BMI variation at referral was explained by premorbid BMI percentile.
Interestingly and in contrast to the effect of premorbid body weight adjusted for age and height, the duration of the eating disorder prior to referral did not explain variation of the BMI at referral. Stated specifically, a longer duration of the eating disorder was not associated with a lower BMI at referral of these adolescent patients. Age in itself also did not significantly affect BMI at referral. In additional analyses, the investigators also found a rather strong correlation for total weight loss in kg/m 2 during the duration of the eating disorder and BMI at referral for inpatient treatment: the higher the weight loss, the higher the BMI at referral. Finally, it should be pointed out that based on this limited number of patients, the average relative premorbid weight was not skewed towards the underweight or overweight range, suggesting that anorexia nervosa can affect females of any body weight with a similar probability.
These initial results have been repeatedly confirmed [6, 13, 15] . Different statistical approaches were used within these confirmatory studies. Miyasaka et al. split their sample based on a premorbid BMI <20.5 or ≥20.5 kg/m 2 and found a difference of 1.1 kg/m 2 for the BMI at referral between the two groups (14.4 ± 1.7 versus 15.5 ± 1.8 kg/m 2 ). Because of this confirmation in this Japanese sample, the effect of premorbid BMI on BMI at referral is seemingly independent of ethnic background. Steinhausen et al. [15] used a logistic regression model to confirm the predictive value of premorbid BMI for BMI at referral in a large sample of 212 young patients with anorexia nervosa (mean age: 15.0 ± 2.7 years). The correlation coefficient between premorbid BMI and BMI at first admission was r = 0.5. While a direct comparison of this coefficient with that detected by Coners et al. is not possible (use of premorbid age percentile for BMI versus premorbid BMI), the magnitude of the correlation appears quite similar. Most recently, Föcker et al. [6] used a multivariate statistical model including the independent variables age, duration of illness, duration of treatment, BMI at admission and BMI percentile at discharge in their analysis based on 161 patients of the (see [10] , for a detailed description of the patient sample) with a mean age of 15.2 ± 1.5 years. Again, the relationship between premorbid BMI percentile and BMI at admission was solidly confirmed. The correlation between premorbid BMI percentile and BMI at referral was 0.45. In addition to premorbid BMI percentile, BMI at admission and age were significant predictors of BMI percentile at discharge. Furthermore, BMI percentile at discharge significantly predicted BMI percentile at 1-year follow-up. An additional analysis that merely included variables available upon referral revealed that premorbid BMI percentile predicted the 1-year follow-up BMI percentile. Steinhausen et al. had previously shown that premorbid BMI predicts BMI after a mean follow-up of 8.3 years (r = 0.2).
Several issues with respect to the predictive value of premorbid body weight for BMI at referral, discharge and follow-up warrant consideration:
1. It appears that premorbid overweight has a beneficial effect on the weight course of patients with anorexia nervosa. Upon admission their BMI is not as low as that of their premorbidly underweight counterparts. In addition, the premorbid overweight entails a higher BMI at discharge and at follow-up. It should be noted that this positive prognostic factor applies to body weight development-it is currently unclear if it entails a better overall prognosis including factors such as psychosocial adjustment and psychiatric comorbidity. It has, for example, been known for a longer period of time that childhood obesity and a positive family history for obesity entail a higher risk for the development of bulimia nervosa [4, 8] ; accordingly, the initially overweight patients likely also have an elevated risk of developing bulimia nervosa after they no longer are underweight. Studies are required to assess differences in temperament, personality and both lifetime and comorbid psychiatric disorders in patients with anorexia nervosa in relationship to premorbid weight category. Furthermore, it is of interest to determine if premorbid obesity and in particular extreme obesity are incompatible with the development of anorexia nervosa during adolescence. Such subjects may not reach the underweight range required for a diagnosis of full blown anorexia nervosa. 2. In pathophysiological terms, it appears that anorexia nervosa does not totally override the mechanisms that apply to body weight regulation in healthy individuals. Thus, tracking of BMI is well known-the shorter apart the time period between initial and follow-up measurements the higher the tracking as assessed by the magnitude of the BMI correlation. Because among adolescent females tracking is high over a 1-to 3-year period, the mere correlation of about r = 0.5 between premorbid BMI and BMI at referral is substantially lower than that to be expected for healthy individuals followed up within a 1-to 2-year period. For example, 3-year BMI correlations for boys and girls aged 9 at initial assessment were >0.8 in a study of US children [12] . 3. Genetic factors figure prominently in BMI tracking [14] and in body weight regulation in general. The number of genes involved in regulation of BMI has increased as delineated in the most recent large-scale meta-analysis of genome-wide association studies [11] ; the studies showing tracking of premorbid BMI and BMI at referral suggest that genes involved in body weight regulation of healthy adolescents also-albeit to a lesser extent-explain variation of BMI at referral of young patients with anorexia nervosa. Alleles of the respective BMI loci may not only contribute to anthropometric characteristics, but also to psychopathological features commonly encountered in patients with eating disorders [7] . Due to the low effect sizes of genetic factors involved in body weight regulation, information on BMI at referral of many patients would be required to indeed prove their effect on BMI at referral. However, due to the fact that (only) 97 genes were identified in the most recent meta-analysis for BMI [11] , p values need not to be adjusted for a genome-wide analysis. As such, the hypothesis can be tested based on currently available genome-wide association data of patients with anorexia nervosa [1] . 4. Because BMI is a composite measure for both heightadjusted fat and fat-free mass, we need to assess if the determination of absolute fat mass, percent body fat mass or fat mass adjusted for height (kg/m 2 ) at referral (unfortunately, a determination of premorbid body composition is not a realistic scenario) results in a higher correlation with height-and age-adjusted premorbid body weight. If premorbid BMI better predicts fat mass (and fat-free mass) at referral than BMI, this would more specifically enable the assessment of genetic, endocrine and environmental parameters involved in the tracking observed in anorexia nervosa. 5. Currently, we do not know if the tracking observed in adolescent patients also holds true for adult patients. A similar analysis of patients with late onset anorexia nervosa is warranted. Because the duration of the eating disorder is typically not that long in adolescents, adult patients should optimally be subdivided into those with a short and long (chronic) duration of anorexia nervosa. 6. Finally, considering the clinical variability of the time point for initiation of inpatient treatment it would prove valuable to identify other predictors of BMI at referral apart from premorbid BMI. Such information could prove valuable for early identification of patients at risk for a low BMI. In addition, such variables may also allow prediction of the medium-and long-term outcome.
